跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMOXICILINA REIWA HEALTHCARE 250 MG POLVO PARA SUSPENSION ORAL EN SOBRE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AMOXICILINA REIWA HEALTHCARE 250 MG POLVO PARA SUSPENSION ORAL EN SOBRE EFG
Approved
STANDARD
AMOXICILINA REIWA HEALTHCARE 250 MG POLVO PARA SUSPENSION ORAL EN SOBRE EFG
Reiwa Healthcare S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 16, 2021
Approval ID
9043b74d12177fe1
Company
Reiwa Healthcare S.L.
Type
Standard
Approval Details
Approval Id
9043b74d12177fe1
Drug Cima Aemps Name
AMOXICILINA REIWA HEALTHCARE 250 MG POLVO PARA SUSPENSION ORAL EN SOBRE EFG
Register Number
85966
Holder Company Name
Reiwa Healthcare S.L.
Marketing Company Name
Reiwa Healthcare S.L.
Authorization Date
2021-05-16
Dosage Form
POLVO PARA SUSPENSIÓN ORAL
Dose
250 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Reiwa Healthcare S.L.
Active Ingredients
AMOXICILINA TRIHIDRATO
295,59 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 16, 2021
Approval ID
9043b74d12177fe1
Type
Standard
Back to CIMA-AEMPS Approvals